Availability of an assay for Detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use - United States, 2013

Morbidity and Mortality Weekly Report

Volumn 62, Issue 41, 2013, Pages 821-824

  Iademarco, Michael F ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ANTIBIOTIC RESISTANCE; DRUG EFFECT; GENETICS; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; LUNG TUBERCULOSIS; METHODOLOGY; MICROBIOLOGY; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NOTE; NUCLEIC ACID AMPLIFICATION; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; UNITED STATES;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DRUG RESISTANCE, BACTERIAL; HUMANS; INFECTION CONTROL; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PRACTICE GUIDELINES AS TOPIC; RIFAMPIN; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 84886900815     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Xpert MTB/RIF assay [package insert]. Sunnyvale, CA: Cepheid; 2013.
2. American Thoracic Society, CDC. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161(4 pt 1):1376-95.
3. CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR 2005;54(No. RR-17).
4. CDC. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR 2009;58:7-10.
5. CDC. Reported tuberculosis in the United States, 2011. Atlanta, GA: U.S Department of Health and Human Services, CDC; 2012. Available at http://www.cdc.gov/tb/statistics/reports/2011.
6. Clinical and Laboratory Standards Institute. Susceptibility testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycete. Approved Standard. Second Edition, M24A2E, Vol. 31, No. 5, 2011.
7. CDC. Report of an expert consultation on the uses of nucleic acid amplification tests for the diagnosis of tuberculosis. Atlanta, GA: U.S Department of Health and Human Services, CDC; 2008. Available at http://www.cdc.gov/tb/topic/laboratory/rapidmoleculartesting/MolDSTreport.pdf.
8. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. Policy statement. Geneva, Switzerland: World Health Organization; 2011. Available at http://apps.who.int/iris/handle/10665/44586.
9. Marks SM, Cronin W, Venkatappa T, et al. The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States. Clin Infect Dis 2013;57:532-42.
10. IDSA/NIH. Prevention and treatment of OI guidelines. Available at http://www.aidsinfo.nih.gov/guidelines.